Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapy.
Respir Med Res. 2020 Nov;78:100788. doi: 10.1016/j.resmer.2020.100788. Epub 2020 Aug 28.
Respir Med Res. 2020.
PMID: 32980653